Friedreich's ataxia

Pediatric Neurology

Volumn 28, Issue 5, 2003, Pages 335-341

  Alper, Gulay ^a   Narayanan, Vinodh ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; ALPHA TOCOPHEROL; ANTIOXIDANT; DEFEROXAMINE; FERRITIN; FRATAXIN; FREE RADICAL; IDEBENONE; IRON; IRON CHELATING AGENT; IRON SULFUR PROTEIN; MITOCHONDRIAL ENZYME; MITOCHONDRIAL PROTEIN; UBIQUINONE;

BABINSKI REFLEX; BIOACCUMULATION; BIOENERGY; CARDIOMYOPATHY; CHROMOSOME 13; CHROMOSOME 9Q; CLINICAL FEATURE; CLINICAL TRIAL; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; DYSARTHRIA; ELECTROCARDIOGRAM; ENZYME ACTIVITY; EVOKED RESPONSE; FAMILIAL DISEASE; FRIEDREICH ATAXIA; GAIT DISORDER; GENE IDENTIFICATION; GENE MAPPING; GENE SEQUENCE; GENETIC DISORDER; HEARING LOSS; HEART PROTECTION; HOMEOSTASIS; HUMAN; IN VITRO STUDY; INTRACELLULAR SPACE; INTRON; LEG; LINKAGE ANALYSIS; MISSENSE MUTATION; MUSCLE ATROPHY; NEUROPHYSIOLOGY; NONSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; ONSET AGE; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PUBERTY; REVIEW; SCAVENGING SYSTEM; SCOLIOSIS; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; TENDON REFLEX; TRINUCLEOTIDE REPEAT; VIBRATION SENSE;

EID: 0037700442     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(03)00004-3     Document Type: Review

References (47)

1. Pandolfo M. Molecular pathogenesis of Friedreich ataxia. Arch Neurol. 56:1999;1201-1208.
2. Geoffroy G., Barbeau A., Breton G., et al. Clinical description and roentgenologic evaluation of patients with Friedreich ataxia. Can J Neurol Sci. 3:1976;279-286.
3. Harding A.E. Friedreich's ataxia A clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain. 104:1981;589-620.
4. Evidente V.G.H., Gwinn-Hardy K.A., Caviness J.N., Gilman S. Hereditary ataxias. Mayo Clin Proc. 75:2000;475-490.
5. Campuzano V., Montermini L., Molto M.D., et al. Friedreich's ataxia Autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 271:1996;1423-1427.
6. Pandolfo M., Montermini L. Molecular genetics of the hereditary ataxias. Adv Genet. 38:1998;31-68.
7. Delatcycki M.B., Williamson M.B., Forrest S.M. Friedreich ataxia An overview. J Med Genet. 37:2000;1-8.
8. Pandolfo M., Montermini L. Prenatal diagnosis of Friedreich Ataxia. Prenat Diagn. 18:1998;831-833.
9. Filla A., De Michele G., Cavalcanti F., et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet. 59:1996;554-560.
10. Epplen C., Epplen J.T., Frank G., Miterski B., Santos E.J.M., Schols L. Differential stability of the (GAA)n tract in Friedreich ataxia (STM7) gene. Hum Genet. 99:1997;834-836.
11. Harding A.E. Clinical features and classification of inherited ataxias. Adv Neurol. 61:1993;1-14.
12. Montermini L., Richter A., Morgan K., et al. Phenotypic variability in Friedreich ataxia Role of the associated GAA triplet repeat expansion. Ann Neurol. 41:1997;675-682.
13. Koenig M. Friedreich ataxia and AVED. In: Scriver CR, Beaudet AL, Sly WS, editors. The metabolic and molecular bases of inherited disease, 8th ed. New York, McGraw-Hill. 2001:5845-55.
14. Durr A., Cossee M., Agid Y., et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med. 335:1996;1169-1175.
15. Delatycki M., Paris D.B.B.P., Gardner R.J.M., et al. Clinical and genetic study of Friedreich ataxia in an Australian population. Am J Med Genet. 87:1999;168-174.
16. Schols L., Amoiridis G., Przuntek H., Frank G., Epplen J.T., Epplen C. Friedreich's ataxia Revision of phenotype according to molecular genetics. Brain. 120:1997;2131-2140.
17. De Michele G., Filla A., Cavalcanti F., et al. Late onset Friedreich's disease Clinical features and mapping of mutation to the FRDA locus. J Neurol Neurosurg Psychiatry. 57:1994;977-979.
18. Palau F., De Michele G., Vilchez J.J., et al. Early-onset ataxia with cardiomyopathy and retained tendon reflexes maps to the Friedreich's ataxia locus on chromosome 9q. Ann Neurol. 37:1995;359-362.
19. Klockgether T., Zuhlke C., Schulz J.B., et al. Friedreich's ataxia with retained tendon reflexes Molecular genetics, clinical neurophysiology, and magnetic resonance imaging. Neurology. 46:1996;118-121.
20. Keats B.J.B., Ward L.J., Shaw J., Wickremasinghe A., Chamberlain S. "Acadian" and "classical" forms of Friedreich ataxia are probably caused by mutations at the same locus. Am J Med Genet. 33:1989;266-268.
21. Lamarche J.B., Lemieux B., Lieu H.B. The neuropathology of "typical" Friedreich's ataxia in Quebec. Can J Neurol Sci. 11:(Suppl. 4):1984;592-600.
22. Said G., Marion M.H., Selva J., Jamet C. Hypotrophic and dying-back nerve fibers in Friedreich's ataxia. Neurology. 36:1986;1292-1299.
23. Priller J., Scherzer R., Faber P.W., MacDonald M.E., Young A.B. Frataxin gene of Friedreich ataxia is targeted to mitochondria. Ann Neurol. 42:1997;265-269.
24. Santoro L., De Michele G., Peretti A., et al. Relation between trinucleotide GAA repeat length and sensory neuropathy in Friedreich's ataxia. J Neurol Neurosurg Psychiatry. 66:1999;93-96.
25. Jitpimolmard S., Small J., King R.H.M., et al. The sensory neuropathy of Friedreich's ataxia An autopsy study of a case with prolonged survival. Acta Neuropathol. 86:1993;29-35.
26. Chamberlain S., Shaw J., Rowland A., et al. Mapping of mutation causing Friedreich's ataxia to human chromosome 9. Nature. 334:1988;248-250.
27. Fujita R., Agid Y., Trouillas P., et al. Confirmation of linkage of Friedreich ataxia to chromosome 9 and identification of a new closely linked marker. Genomics. 4:1989;110-111.
28. Pandolfo M., Sirugo G., Antonelli A., et al. Friedreich ataxia in Italian families Genetic homogeneity and linkage disequilibrium with the marker loci D9S5 and D9S15. Am J Hum Genet. 47:1990;228-235.
29. Chamberlain S., Farrall M., Shaw J., et al. Genetic recombination events which position the Friedreich ataxia locus proximal to the D9S15/D9S5 linkage group on chromosome 9q. Am J Hum Genet. 52:1993;99-109.
30. Cossee M., Durr A., Scmitt M., et al. Friedreich's ataxia Point mutations and clinical presentations of compound heterozygotes. Ann Neurol. 45:1999;200-206.
31. Bidichandani S.I., Ashizawa T., Patel P.I. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am J Hum Genet. 62:1998;111-121.
32. Sakamato N., Chastain P.D., Parniewski P., et al. Sticky DNA Self-association properties of long GAA TTC repeats in RR Y triplex structures from Friedreich's ataxia. Mol Cell. 3:1999;465-475.
33. Forrest S.M., Knight M., Delatcyki M., et al. The correlation of clinical phenotype with the site of point mutations in FRDA gene. Neurogenetics. 1:1998;253-257.
34. Ragno W., De Michele G., Cavalcanti F., et al. Broadened Friedreich's ataxia phenotype after gene cloning. Neurology. 49:1997;1617-1620.
35. Lodi R., Cooper J.M., Bradley J.L., et al. Deficit of in vivo mitochondrial ATP production in patients with Friedreich's ataxia. Proc Natl Acad Sci. 96:1999;11492-11495.
36. Puccio H., Koenig M. Recent advances in the molecular pathogenesis of Friedreich ataxia. Hum Mol Gen. 9:2000;887-892.
37. Babcock M., de Silva D., Oaks R., et al. Regulation of mitochondrial iron accumulation by Yfh 1p, a putative homolog of frataxin. Science. 276:1997;1709-1712.
38. Delatycki M., Camakaris M., Brooks H., et al. Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia. Ann Neurol. 45:1999;673-675.
39. Rotig A., de Lonlay P., Chretien D., et al. Aconitase and mitochondrial iron-sulfur protein deficiency in Friedreich ataxia. Nat Genet. 17:1997;215-217.
40. Bradley J.L., Blake J.C., Chamberlain S., Thomas P.K., Cooper J.M., Schapira A.H. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum Mol Gen. 9:2000;275-282.
41. Puccio H., Simon D., Cossee M., et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet. 27:2001;181-186.
42. Koutnikova H., Campuzano V., Foury F., Dolle P., Cazzalini O., Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet. 16:1997;345-351.
43. Wilson R.B., Lynch D.R., Fischbeck K.H. Normal serum iron and ferritin concentrations in patients with Friedreich's ataxia. Ann Neurol. 44:1998;132-134.
44. Rustin P., von Kleist-Retzow J.C., Chantrel-Groussard K., Sidi D., Munnich A., Rotig A. Effect on idebenone on cardiomyopathy in Friedreich's ataxia A preliminary study. Lancet. 354:1999;477-479.
45. Rustin P., Rotig A., Munnich A., Sidi D. Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia. Free Radic Res. 36:2002;467-469.
46. Lodi R., Hart P.E., Rajagopolan B., et al. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann Neurol. 49:2001;590-596.
47. Lodi R., Rajagopolan B., Bradley J.L., et al. Mitochondrial dysfunction in Fredreich's ataxia From pathogenesis to treatment perspectives. Free Radic Res. 36:2002;461-466.